|
PCSA Processa Pharmaceuticals Inc 1533743 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,377,179.00 |
| Balance Sheet |
|
Current Assets
|
$1,938,406.00 |
|
Assets
|
$4,520,974.00 |
|
Current Liabilities
|
$1,980,093.00 |
|
Liabilities
|
$1,980,093.00 |
|
Equity
|
$2,540,881.00 |
|
Shares Out
|
2677835.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,590,695.00 |
|
Investing Cash Flow
|
$-500,000.00 |
| Market Analysis |
Market Cap
|
$5,462,783.40 |
|
Price
|
$2.11 |
|
BVPS
|
0.95 |
|
PB
|
2.15 |
|
EPS
|
-1.29 |
|
FCF
|
$-3,593,939.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PCSA documents filed with the SEC.
PCSA Filings
Clear
